Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Research aims to improve job search skills among mid-career workers from lower SES families

Mei is a mid-career woman looking for a job. She worked at an international hotel chain after junior college for 14 years and climbed through the ranks to become a housekeeping supervisor.

16 Sep 2021

NIH awards funding to build a national study population of volunteers on long-term effects of COVID-19

The National Institutes of Health awarded nearly $470 million to build a national study population of diverse research volunteers and support large-scale studies on the long-term effects of COVID-19.

15 Sep 2021

Analysis of the immune landscape in mild-to-moderate COVID-19

A new study includes an analysis of plasma cytokine levels, peripheral blood immune cell composition, and SARS-CoV-2 specific Igs in COVID-19.

15 Sep 2021

Pew announces support for the 2021 class of Innovation Fund investigators

The Pew Charitable Trusts announced today the six pairs of researchers who will make up its 2021 class of Innovation Fund investigators.

15 Sep 2021

Phase I trial investigates using antiparasitic nitazoxanide for treatment of COVID-19

In a recent study, researchers investigate the possibility of using the thiazolide antiparasitic nitazoxanide for the treatment of COVID-19.

15 Sep 2021

Over half of states have rolled back public health powers in pandemic

Republican legislators in more than half of U.S. states, spurred on by voters angry about lockdowns and mask mandates, are taking away the powers state and local officials use to protect the public against infectious diseases.

15 Sep 2021

Respiratory emissions during labor and delivery can increase the risk of disease transmission

Some medical procedures can put health care workers at higher risk for contracting COVID-19 and other respiratory diseases.

15 Sep 2021

UK Sepsis Trust calls for people to better understand the signs and symptoms of sepsis

This World Sepsis Day, the UK Sepsis Trust is calling for people to better understand the signs and symptoms of sepsis and recognize it as a medical emergency, in order to reduce the risk of death and mitigate against the very real long-term health effects of post-sepsis syndrome.

15 Sep 2021

New automated approach to detecting SARS-CoV-2 variants with increased growth rates

Researchers in the United States have developed a new automated approach to detecting variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – that have increased growth rates over other lineages.

15 Sep 2021

Pregnancy complications with COVID-19

An important new article published in the Clinical Medicine Journal discusses pregnancy complicated with COVID-19.

14 Sep 2021

Flu shots and COVID-19 immunity

A new paper finds that the influenza vaccine may influence both the response to and incidence of infection by the SARS-CoV-2.

14 Sep 2021

Low dose of Moderna COVID-19 vaccine generates durable immune response

A new study from La Jolla Institute for Immunology (LJI) scientists helps answer the question: how long does immunity against COVID-19 last in vaccinated people?

14 Sep 2021

Health leaders issue an urgent call for vaccine equity globally and in Africa

WHO Director-General Dr Tedros Adhanom Ghebreyesus and a group of global health leaders today issued an urgent call for vaccine equity globally and in Africa in particular.

14 Sep 2021

COVID-19 booster vaccine to be offered to millions of vulnerable people from next week

Millions of vulnerable people are to be offered a COVID-19 booster vaccine from next week as the government confirms it has accepted the final advice from the independent Joint Committee on Vaccination and Immunisation (JCVI).

14 Sep 2021

Gorillas at Atlanta Zoo have been infected by SARS-CoV-2

At Zoo Atlanta, 18 western lowland gorillas are currently receiving treatment for COVID-19 as initial and tests came back positive.

14 Sep 2021

Immune-mediated inflammatory disease may increase risk of severe COVID-19 outcomes

Researchers in the UK have conducted a large population-based study showing that people with immune-mediated inflammatory diseases (IMIDs) appear to be at an increased risk of serious outcomes from coronavirus disease 2019 (COVID-19).

14 Sep 2021

Metabolic and immune markers as tools for risk stratification and monitoring in COVID-19

In a new study posted to the medRxiv* server scientists from Weil Cornell University and Stony Brook University in New York attempted to identify the metabolic and immune markers associated with severe COVID-19 disease using high-throughput targeted nuclear magnetic resonance (NMR) spectroscopy and high-dimensional flow cytometry. This will facilitate risk stratification, monitoring, and therapeutic interventions in COVID-19 patients.

14 Sep 2021

A review of mesenchymal stem cell therapy for severe COVID-19

Researchers find that MSC treatment is highly tolerated and effective in reducing lung damage in COVID-19 patients and improving their chances of recovery.

13 Sep 2021

Australia's response to COVID-19 pandemic

In a recent paper, Australia's response to the COVID-19 pandemic is described, identifying the factors that contributed most to the countries success.

13 Sep 2021

Low-dose CT lung cancer screening linked to reduction in lung cancer mortality

Low-dose CT lung cancer screening is associated with a 16 percent relative reduction in lung cancer mortality, when compared against a non-LDCT control arm, according to research presented by Professor John Field and the United Kingdom Cancer Screening Trial (UKLS) Team today at the IASLC 2021 World Conference on Lung Cancer. The research will be published in the Lancet Regional Health-Europe.

13 Sep 2021

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Research aims to improve job search skills among mid-career workers from lower SES families

NIH awards funding to build a national study population of volunteers on long-term effects of COVID-19

Analysis of the immune landscape in mild-to-moderate COVID-19

Pew announces support for the 2021 class of Innovation Fund investigators

Phase I trial investigates using antiparasitic nitazoxanide for treatment of COVID-19

Over half of states have rolled back public health powers in pandemic

Respiratory emissions during labor and delivery can increase the risk of disease transmission

UK Sepsis Trust calls for people to better understand the signs and symptoms of sepsis

New automated approach to detecting SARS-CoV-2 variants with increased growth rates

Pregnancy complications with COVID-19

Flu shots and COVID-19 immunity

Low dose of Moderna COVID-19 vaccine generates durable immune response

Health leaders issue an urgent call for vaccine equity globally and in Africa

COVID-19 booster vaccine to be offered to millions of vulnerable people from next week

Gorillas at Atlanta Zoo have been infected by SARS-CoV-2

Immune-mediated inflammatory disease may increase risk of severe COVID-19 outcomes

Metabolic and immune markers as tools for risk stratification and monitoring in COVID-19

A review of mesenchymal stem cell therapy for severe COVID-19

Australia's response to COVID-19 pandemic

Low-dose CT lung cancer screening linked to reduction in lung cancer mortality

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Newsletters you may be interested in